Skip to main content
Erschienen in: Calcified Tissue International 3/2005

01.09.2005

Influence of Hyper- and Hypothyroidism, and the Effects of Treatment with Antithyroid Drugs and Levothyroxine on Fracture Risk

verfasst von: P. Vestergaard, L. Rejnmark, L. Mosekilde

Erschienen in: Calcified Tissue International | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to assess alterations in fracture risk in patients with hyper- and hypothyroidism, and the effects of antithyroid drugs and levothyroxine on fracture risk. The study was designed as a case–control study. All patients with a fracture (n = 124,655) in the year 2000 in Denmark served as cases. For each case, three age- and gender-matched controls were randomly drawn from the general population (n = 373,962). Exposure variables were a diagnosis of hyperthyroidism, hypothyroidism, ever use of antithyroid drugs, and ever use of levothyroxine. Adjustments were made for time since diagnosis, surgery for hyperthyroidism, thyroid cancer, prior fracture, alcoholism, and corticosteroid use. There was an increase in the risk of any fracture within the first 5 years after a diagnosis of hyperthyroidism, and the first 10 years after a diagnosis of hypothyroidism. Use of antithyroid drugs was associated with a significantly reduced fracture risk independently of the dose used (odds ratio [OR] 0.79–0.84, 2P < 0.05). No effect of levothyroxine on fracture risk was present. Thyroid surgery for hyperthyroidism and thyroid cancer were not associated with fracture risk. A prior fracture, alcoholism, and corticosteroid use were significant risk factors for fractures. Fracture risk is increased at the time of diagnosis of both hyper- and hypothyroidism, and this increase seems reversible. Low-dose levothyroxine was not associated with fracture risk. The effect of antithyroid drugs may be caused by the reduction in thyroid hormone levels.
Literatur
1.
Zurück zum Zitat Eriksen EF, Mosekilde L, Melsen F (1985) Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6:421–428CrossRefPubMed Eriksen EF, Mosekilde L, Melsen F (1985) Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6:421–428CrossRefPubMed
2.
Zurück zum Zitat Mosekilde L, Melsen F, Bagger JP, et al. (1977) Bone changes in hyperthyroidism: interrelationships between bone histomorphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol 85:515–525PubMed Mosekilde L, Melsen F, Bagger JP, et al. (1977) Bone changes in hyperthyroidism: interrelationships between bone histomorphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol 85:515–525PubMed
3.
Zurück zum Zitat Ross DS (1994) Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 4:319–326PubMed Ross DS (1994) Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 4:319–326PubMed
4.
Zurück zum Zitat Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35–63PubMed Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35–63PubMed
5.
Zurück zum Zitat Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk—a meta-analysis. Thyroid 13:585–593CrossRefPubMed Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk—a meta-analysis. Thyroid 13:585–593CrossRefPubMed
6.
Zurück zum Zitat Coindre JM, David JP, Riviere I, et al. (1986) Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med 146:48–53CrossRefPubMed Coindre JM, David JP, Riviere I, et al. (1986) Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med 146:48–53CrossRefPubMed
7.
Zurück zum Zitat Mosekilde L, Melsen F (1978) Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand [A] 86:56–62 Mosekilde L, Melsen F (1978) Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathol Microbiol Scand [A] 86:56–62
8.
Zurück zum Zitat Abu EO, Bord S, Horner A, et al. (1997) The expression of thyroid hormone receptors in human bone. Bone 21:137–142CrossRefPubMed Abu EO, Bord S, Horner A, et al. (1997) The expression of thyroid hormone receptors in human bone. Bone 21:137–142CrossRefPubMed
9.
Zurück zum Zitat Mazziott G, Sorvillo F, Piscopo M, et al. (2005) Recombinant human TSH modulates in vivo C-telopeptides of type- 1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20:480–486PubMed Mazziott G, Sorvillo F, Piscopo M, et al. (2005) Recombinant human TSH modulates in vivo C-telopeptides of type- 1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. J Bone Miner Res 20:480–486PubMed
10.
Zurück zum Zitat Ribot C, Tremollieres F, Pouilles JM, et al. (1990) Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 33:143–153 Ribot C, Tremollieres F, Pouilles JM, et al. (1990) Bone mineral density and thyroid hormone therapy. Clin Endocrinol (Oxf) 33:143–153
11.
Zurück zum Zitat Trémollières F, Pouillès JM, Louvet JP, et al. (1991) [Transitory bone loss during substitution treatment for hypothyroidism. Results of a two year prospective study. Rev Rhum Mal Osteoartic 58:869–875 [French]PubMed Trémollières F, Pouillès JM, Louvet JP, et al. (1991) [Transitory bone loss during substitution treatment for hypothyroidism. Results of a two year prospective study. Rev Rhum Mal Osteoartic 58:869–875 [French]PubMed
12.
Zurück zum Zitat Vestergaard P, Weeke J, Hoeck HG, et al. (2000) Fractures in patients with primary idiopathic hypothyroidism. Thyroid 10:335–340PubMed Vestergaard P, Weeke J, Hoeck HG, et al. (2000) Fractures in patients with primary idiopathic hypothyroidism. Thyroid 10:335–340PubMed
13.
Zurück zum Zitat Uzzan B, Campos J, Cucherat M, et al. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289CrossRefPubMed Uzzan B, Campos J, Cucherat M, et al. (1996) Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis. J Clin Endocrinol Metab 81:4278–4289CrossRefPubMed
14.
Zurück zum Zitat Vestergaard P, Rejnmark L, Weeke J, et al. (2000) Fracture risk in patients treated for hyperthyroidism. Thyroid 10:341–348PubMed Vestergaard P, Rejnmark L, Weeke J, et al. (2000) Fracture risk in patients treated for hyperthyroidism. Thyroid 10:341–348PubMed
15.
Zurück zum Zitat Mosekilde L, Melsen F (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: bone histomorphometry. Acta Endocrinol (Copenh) 87:751–758 Mosekilde L, Melsen F (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: bone histomorphometry. Acta Endocrinol (Copenh) 87:751–758
16.
Zurück zum Zitat Mosekilde L, Christensen MS, Melsen F, et al. (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: chemical quantities in serum and urine. Acta Endocrinol (Copenh) 87:743–750 Mosekilde L, Christensen MS, Melsen F, et al. (1978) Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. I: chemical quantities in serum and urine. Acta Endocrinol (Copenh) 87:743–750
17.
Zurück zum Zitat Jodar E, Munoz-Torres M, Escobar-Jimenez F, et al. (1997) Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab 82:1989–1994CrossRefPubMed Jodar E, Munoz-Torres M, Escobar-Jimenez F, et al. (1997) Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab 82:1989–1994CrossRefPubMed
18.
Zurück zum Zitat Faber J, Jensen IW, Petersen L, et al. (1998) Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf) 48:285–290CrossRef Faber J, Jensen IW, Petersen L, et al. (1998) Normalization of serum thyrotropin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women. Clin Endocrinol (Oxf) 48:285–290CrossRef
19.
Zurück zum Zitat Wacholder S, McLaughlin JK, Silverman DT, et al. (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019–1028 Wacholder S, McLaughlin JK, Silverman DT, et al. (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019–1028
20.
Zurück zum Zitat Vestergaard P, Emborg C, Støving RK, et al. (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nation-wide register study. Int J Eating Disord 32:301–308CrossRef Vestergaard P, Emborg C, Støving RK, et al. (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders—a nation-wide register study. Int J Eating Disord 32:301–308CrossRef
21.
Zurück zum Zitat Klotzbuecher CM, Ross PD, Landsman PB, et al. (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesis. J Bone Miner Res 15:721–739PubMed Klotzbuecher CM, Ross PD, Landsman PB, et al. (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesis. J Bone Miner Res 15:721–739PubMed
22.
Zurück zum Zitat Kanis JA, Johansson H, Johnell Q, et al. (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16: 737–742CrossRefPubMed Kanis JA, Johansson H, Johnell Q, et al. (2005) Alcohol intake as a risk factor for fracture. Osteoporos Int 16: 737–742CrossRefPubMed
23.
Zurück zum Zitat Andergen TF, Madsen M, Jørgensen J, et al. (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMed Andergen TF, Madsen M, Jørgensen J, et al. (1999) The Danish National Hospital Register. Dan Med Bull 46:263–268PubMed
24.
Zurück zum Zitat Munk-Jørgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82–84PubMed Munk-Jørgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82–84PubMed
25.
Zurück zum Zitat Mosbech J, Jørgensen J, Madsen M, et al. (1995) [The Danish National Patient Register: evaluation of data quality. Ugeskr Lasger 157:3741–3745 [Danish] Mosbech J, Jørgensen J, Madsen M, et al. (1995) [The Danish National Patient Register: evaluation of data quality. Ugeskr Lasger 157:3741–3745 [Danish]
26.
Zurück zum Zitat Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1–10CrossRefPubMed Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1–10CrossRefPubMed
27.
Zurück zum Zitat Larsen ER, Mosekilde L, Foldspang A (2004) Correlates of falling during 24 h among elderly Danish community residents. Prev Med 39:389–398CrossRefPubMed Larsen ER, Mosekilde L, Foldspang A (2004) Correlates of falling during 24 h among elderly Danish community residents. Prev Med 39:389–398CrossRefPubMed
28.
Zurück zum Zitat Schwartz AV, Villa ML, Prill M, et al. (1999). Falls in older Mexican-American women. J Am Geriatr Soc 47:1371–1378PubMed Schwartz AV, Villa ML, Prill M, et al. (1999). Falls in older Mexican-American women. J Am Geriatr Soc 47:1371–1378PubMed
29.
Zurück zum Zitat Vestergaard P, Rejnmark L, Weeke J, et al. (2002) Smoking as a risk factor for Graves’ disease, toxic nodular goitre, and primary idiopathic hypothyroidism. Thyroid 12:69–75CrossRefPubMed Vestergaard P, Rejnmark L, Weeke J, et al. (2002) Smoking as a risk factor for Graves’ disease, toxic nodular goitre, and primary idiopathic hypothyroidism. Thyroid 12:69–75CrossRefPubMed
Metadaten
Titel
Influence of Hyper- and Hypothyroidism, and the Effects of Treatment with Antithyroid Drugs and Levothyroxine on Fracture Risk
verfasst von
P. Vestergaard
L. Rejnmark
L. Mosekilde
Publikationsdatum
01.09.2005
Erschienen in
Calcified Tissue International / Ausgabe 3/2005
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-005-0068-x

Weitere Artikel der Ausgabe 3/2005

Calcified Tissue International 3/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.